Company Overview and News

32
EU mergers and takeovers (Oct 19)

1h reuters
BRUSSELS, Oct 19 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
LBTY DTEGF WHR 500470 LBTYK LILAB KWR DIS DLELY AVOL AWI FOX SPR LBTYB LBTYA IDL SNEJF BKNG TTST TATASTEEL TATLY LILAK SNE MSFT HPQ FOXA DTEGY LILA

10
What to Know Before Investing in Augmented & Virtual Reality

3h zacks
On a special edition of the Zacks Friday Finish Line, hosts Ryan McQueeney and Maddy Johnson are joined by Bryce Tillery of Eve Capital, the sponsor of the Tactile Analytics ETF (ARVR - Free Report) , to discuss investing in augmented and virtual reality.
GPRO BLT BHP BHPBF BBL MSFT SNE FINL BHP BHPLF

7
If You Can Stand the Volatility, Turtle Beach Stock Is a Compelling Trade

10h investorplace
Turtle Beach (NASDAQ:HEAR) has gained attention as its stock has surged. The San Diego-based manufacturer of gaming headphones has emerged from penny-stock status as it profits from a currently popular gaming niche. After starting the year at below $2 per share, Turtle Beach stock now hovers in the $22 range.
ROKU HEAR MSFT SNE

9
Eight Japan firms listed in best global brand report; Apple holds top spot

2018-10-18 japantimes.co.jp
NEW YORK – Toyota Motor Corp. and seven other Japanese firms have made it into a 2018 global brand ranking while Apple Inc., based in the United States, maintained its top spot for the sixth straight year.
PCRFY FB TM AAPL 7203 CAJ TYT SNE SNEJF TOYOF

5
Sony (SNE) Gains As Market Dips: What You Should Know

2018-10-17 zacks
Sony (SNE - Free Report) closed at $57.89 in the latest trading session, marking a +0.68% move from the prior day. This change outpaced the S&P 500's 0.03% loss on the day. Meanwhile, the Dow lost 0.36%, and the Nasdaq, a tech-heavy index, lost 0.04%.
OLBK SNE RLI

8
Tokyo stocks extend their rally on buybacks

2018-10-17 japantimes.co.jp
Stocks extended a rally on the Tokyo Stock Exchange on Wednesday, boosted by buybacks in the wake of a sharp overnight rebound on Wall Street.
NMR MZHOF SMFG SMFNF TOELY 8604 8306 NRSCF 8766 TKOMY MS TOELF MBFJF TKOMF SNEJF N33 8316 MUFG SNE 8411 8750 8035 MTU MFG

5
EU regulators ask Sony's rivals and users how it might use power after EMI deal

2018-10-16 reuters
BRUSSELS (Reuters) - EU antitrust regulators reviewing Sony Corp’s $2.3 billion bid for EMI are asking rivals and users whether they think the Japanese group would use its greater market power to win better terms in digital media deals.
SNE SNEJF

5
EU regulators ask Sony's rivals and users how it might use power after EMI deal

2018-10-16 channelnewsasia
EU antitrust regulators reviewing Sony Corp's US$2.3 billion bid for EMI are asking rivals and users whether they think the Japanese group would use its greater market power to win better terms in digital media deals.
SNE SNEJF

5
Amid Japan’s changing work-style landscape, office space provider WeWork grows at a dizzying pace

2018-10-16 japantimes.co.jp
The seven-story tower with a glass exterior near Tokyo’s trendy Omotesando district serves not just a co-working space with computers and free Wi-Fi. There is also a pantry, a bar counter and a spacious lounge where you can drink freshly roasted coffee and beer on tap free of charge. There is even a room for meditation or prayer.
KWHIF MARUF KWHIY SNE SFTBF 9984 7012 SNEJF 8630 SFTBY

33
EU mergers and takeovers (Oct 15)

2018-10-15 reuters
BRUSSELS, Oct 15 (Reuters) - The following are mergers under review by the European Commission and a brief guide to the EU merger process:
4091 LBTY DTEGF WHR 500470 LBTYK LILAB DIS DLELY AVOL FOX SPR LBTYB LBTYA IDL CG SNEJF BKNG TTST TATASTEEL TATLY LILAK SNE MSFT HPQ FOXA DTEGY LILA

10
The Zacks Analyst Blog Highlights: Sony, Nikon, Kyocera and Suzuki Motor

2018-10-15 zacks
Chicago, IL – October 15, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Sony Corporation (SNE - Free Report) , Nikon Corporation (NINOY - Free Report) , Kyocera Corporation (KYOCY - Free Report) and Suzuki Motor Corporation (SZKMY - Free Report) .
WFC WFCNP SNEJF KYO 7269 VSH HEAR SNE NINOY

26
6 Most Important Things In Business Today–Sears Chapter 11

2018-10-15 247wallst
Sears Holdings Corp filed for Chapter 11 bankruptcy on Monday with a plan to close 142 more stores, throwing into doubt the future of the century-old retailer that once dominated U.S. malls but has withered in the age of internet shopping.
CCF SHLD GS GLSSP BOE JBK F GSC TFG MA GSJ JPM SNE SHLDW HRS GJS BA

23
‘First Man’ blasts off behind ‘Venom,’ ‘A Star Is Born’

2018-10-14 entertainment.inquirer.net
This image released by Universal Pictures shows Ryan Gosling in a scene from “First Man.” (Universal Pictures via AP)
VIA LGF CCV CMCSA TWX CCZ SNEJF TWC AMCX VIAB CCV.CL LGF.A SNE LGF.B CMCSK DIS

5
Nam June Paik—‘Father of video art’ who never watched TV

2018-10-14 lifestyle.inquirer.net
Ken Hakuta, nephew of Nam June Paik who is the custodian of the late artist’s estate —PHOTOS BY DEXTER R. MATILLA
SNE SNEJF

260
Stocks To Watch: Was That A Speed Bump?

2018-10-13 seekingalpha - 6
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GLBS PERY PSX LCII ABT CRM SHPG CSCO MS AMC COF-P SMPL ISRG SYF DVMT IDA JNJ HON.WI MSFT HLUKF LEVL FTCH APHQF UTHR MTW ADS FB SCL NFLX AXP SKX SU BAC COF-D COF-C COF-F AAPL CCI ELAN HUBB CE SU EB SURF TRIP PVTL GSK EOG SIX JPM PATK SBUX CNTTF KMRFZ CNC CNK WMT NKE SHAK AMZN HON KMI TWTR HCSG GSK TRMB EAF KMR AA DXC CVB EBAY REGN SLB BAC DFS CRON STBA SC UAL GOOGL LTXB AHBIF PENN SCL SLB QCOM WFCNP XLNX PM PG PNK CPB PYPL VMW WGO TLRY USB GS MYL JEC SWI XYF WEED DXC.WI ECL ABT IBM CWH WFC HON BUD C TPR CMCSA THO COF BSVN LECO CGC SNY VLTHF V SCHW HP T MRK SNE DPZ

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to SNE / Sony Corp. on message board site Silicon Investor.

disney!!! (DIS) disney!!! (DIS) disney!!! (DIS) SNE - Sony Corp - ADR SNE - Sony Corp - ADR SNE - Sony Corp - ADR
New Pearl Harbour Ride At Disneyland New Pearl Harbour Ride At Disneyland New Pearl Harbour Ride At Disneyland Sony Playstation Sony Playstation Sony Playstation
DISsing DISney DISsing DISney DISsing DISney Organogenesis - a tissue engineering worth sneezing about? Organogenesis - a tissue engineering worth sneezing about? Organogenesis - a tissue engineering worth sneezing about?
Hotel california now open for buisness Hotel california now open for buisness Hotel california now open for buisness Walt Disney Internet Group - DIG Walt Disney Internet Group - DIG Walt Disney Internet Group - DIG
CSNE Compressent Technology CSNE Compressent Technology CSNE Compressent Technology CLAI - http://www.claimsnet.com CLAI - http://www.claimsnet.com CLAI - http://www.claimsnet.com
CUSIP: 835699307